Main outcome measures
Management of epistaxis, admission rates and re-presentation rates were recorded over seven months pre-implementation, from 01/08/2019-29/02/2020 (n=159), and eight months post-implementation, from 01/08/2020-31/03/2021 (n=86).  Data was not collected during the height of the covid-19 pandemic (March 2020 to July 2020), due to the confounding effect on admission rates.
Statistical analysis was performed using the two-proportion z-test, with a significance level p <0.05.
Reporting is in line with the SQUIRE 2.0 framework for quality improvement.